BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31788754)

  • 1. Exploring Microsatellite Instability (MSI) in Colorectal Cancer at Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST).
    Kurbatov V; Khan SA
    Ann Surg Oncol; 2020 Apr; 27(4):973-974. PubMed ID: 31788754
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
    Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
    Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
    Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
    Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
    Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
    Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
    J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
    Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
    Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
    J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
    Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
    Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
    J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients.
    Pirini F; Pasini L; Tedaldi G; Scarpi E; Marisi G; Molinari C; Calistri D; Passardi A; Ulivi P
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.
    Wang Y; Vnencak-Jones CL; Cates JM; Shi C
    J Mol Diagn; 2018 May; 20(3):366-372. PubMed ID: 29474982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
    Venderbosch S; van Lent-van Vliet S; de Haan AF; Ligtenberg MJ; Goossens M; Punt CJ; Koopman M; Nagtegaal ID
    PLoS One; 2015; 10(4):e0124538. PubMed ID: 25884216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer.
    Watson MM; Berg M; Søreide K
    Br J Cancer; 2014 Aug; 111(5):823-7. PubMed ID: 24691426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.
    Lee SY; Miyai K; Han HS; Hwang DY; Seong MK; Chung H; Jung BH; Devaraj B; McGuire KL; Carethers JM
    Dig Dis Sci; 2012 Jan; 57(1):72-8. PubMed ID: 21773681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMAST frequency in colorectal cancer: a meta-analysis and literature review.
    Ranjbar R; Esfahani AT; Nazemalhosseini-Mojarad E; Olfatifar M; Aghdaei HA; Mohammadpour S
    Biomark Med; 2020 Jul; 14(11):1021-1030. PubMed ID: 32940074
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
    Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
    Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for discovering EMAST sequences in animal models of cancer.
    Bhaskaran N; Luu J; Kelley ST; Khan MW; Mamindla P; McGuire KL
    Sci Rep; 2018 Sep; 8(1):13764. PubMed ID: 30214002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
    Catto JW; Azzouzi AR; Amira N; Rehman I; Feeley KM; Cross SS; Fromont G; Sibony M; Hamdy FC; Cussenot O; Meuth M
    Oncogene; 2003 Nov; 22(54):8699-706. PubMed ID: 14647464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.